Indeed, two pancreatic cancer cell lines (COLO-357 and PANC-1) were treated with phosphoinositide-specific phospolipase-C (PI-PLC), an enzyme responsible for the release of GPC1 from the cell membrane by GPI-anchor cleaving. The gene discussed is GPC1; the disease is pancreatic neoplasm.